risperidone has been researched along with leptin in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 14 (56.00) | 29.6817 |
2010's | 11 (44.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, K; Itoh, M; Kaneko, YS; Mori, K; Nagasaka, A; Nakashima, A; Ota, A; Ota, M | 1 |
Atmaca, M; Kuloglu, M; Tezcan, E; Ustundag, B | 1 |
Basile, VS; Kennedy, SH; Mancini, DA; McIntyre, RS; Srinivasan, J | 1 |
de Castella, AR; Fitzgerald, PB; Kulkarni, J; Morris, MJ; Scaffidi, A | 1 |
Aman, M; Anderson, GM; Arnold, LE; Chuang, S; Martin, A; McCracken, J; McDougle, CJ; Scahill, L; Tierney, E; Vitiello, B | 1 |
Baptista, T; Beaulieu, S; de Baptista, EA; Joober, R; Kin, NM; Lalonde, J; Plamondon, J; Richard, D | 1 |
Kostulski, A; Rabe-Jabłońska, J; Wyszogrodzka-Kucharska, A | 1 |
Rustembegovic, A; Sofic, E; Wichart, I | 1 |
Hosoda, H; Inoue, T; Itoh, K; Izumi, T; Kangawa, K; Koyama, T; Kusumi, I; Murashita, M; Nakagawa, S; Tanaka, T | 1 |
Anjum, N; Cheetham, S; Dickinson, K; Fell, MJ; Marshall, KM; Neill, JC; Peltola, LM; Vickers, S | 1 |
Cooper, T; Usubiaga, H; Winsberg, B | 1 |
Amado, JA; Berja, A; Carrasco-Marín, E; Crespo-Facorro, B; Garcia-Unzueta, MT; Mata, I; Pelayo-Terán, JM; Perez-Iglesias, R; Vazquez-Barquero, JL | 1 |
Gorobets, LN | 1 |
Acion, L; Calarge, CA; Ellingrod, VL; Schlechte, JA; Sivitz, WI; Zimmerman, B | 1 |
Maayan, LA; Vakhrusheva, J | 1 |
Chang, CM; Chang, PY; Huang, TL; Liu, CY; Tsai, MC | 1 |
Fukui, N; Ono, S; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J | 1 |
Aman, MG; Arnold, LE; Handen, B; Johnson, C; Lecavalier, L; McCracken, JT; McDougle, CJ; Nurmi, EL; Posey, DJ; Ritz, L; Scahill, LL; Spilman, SL; Stigler, KA; Sukhodolsky, DG; Tierney, E; Vitiello, B; Whelan, F | 1 |
Ak, M; Kursungoz, C; Sutcigil, L; Yanik, T | 1 |
Hur, GM; Kim, JL; Kong, G; Li, Y; Park, J; Piao, L; Shin, S; Shrestha, R; Tran, Q | 1 |
Ak, M; Kursungoz, C; Yanik, T | 1 |
Arango, C; Baeza, I; Calvo-Escalona, R; Castro-Fornieles, J; de la Serna, E; Merchán-Naranjo, J; Rodríguez-Latorre, P; Vigo, L | 1 |
Hongkaew, Y; Intachak, B; Kroll, MH; Limsila, P; Ngamsamut, N; Puangpetch, A; Srisawasdi, P; Sukasem, C; Vanavanan, S; Vanwong, N | 1 |
Horska, K; Karpisek, M; Kotolova, H; Opatrilova, R; Ruda-Kucerova, J; Suchy, P | 1 |
Bansal, Y; Kuhad, A; Medhi, B; Saroj, P; Singh, R; Sodhi, RK | 1 |
1 review(s) available for risperidone and leptin
Article | Year |
---|---|
[Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
Topics: Antipsychotic Agents; Body Weight; Clozapine; Dibenzothiazepines; Humans; Hyperlipidemias; Leptin; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles; Weight Gain | 2005 |
6 trial(s) available for risperidone and leptin
Article | Year |
---|---|
Antipsychotic-induced weight gain: bipolar disorder and leptin.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Female; Humans; Leptin; Lithium; Male; Middle Aged; Olanzapine; Pirenzepine; Risperidone; Valproic Acid; Weight Gain | 2003 |
The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Gonadal Steroid Hormones; Humans; Leptin; Middle Aged; Neuropeptide Y; Olanzapine; Pirenzepine; Radioimmunoassay; Risperidone; Schizophrenia; Time Factors; Weight Gain | 2003 |
Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Autistic Disorder; Body Mass Index; Body Weight; Child; Child, Preschool; Female; Humans; Leptin; Male; Prospective Studies; Risperidone; Weight Gain | 2004 |
Ghrelin and leptin response to oral glucose challenge among antipsychotic drug-treated children.
Topics: Administration, Oral; Adolescent; Age Factors; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Blood Glucose; Body Mass Index; Child; Chlorpromazine; Fasting; Female; Ghrelin; Glucose; Glucose Tolerance Test; Humans; Insulin; Leptin; Male; Piperazines; Quinolones; Risperidone; Sex Factors; Time Factors; Weight Gain | 2007 |
Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment.
Topics: Adiponectin; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Body Composition; Body Mass Index; Dose-Response Relationship, Drug; Energy Metabolism; Female; Ghrelin; Haloperidol; Humans; Insulin; Leptin; Male; Middle Aged; Nicotinamide Phosphoribosyltransferase; Olanzapine; Prospective Studies; Psychotic Disorders; Resistin; Risperidone; Schizophrenia; Weight Gain | 2008 |
Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment.
Topics: Adolescent; Anthropometry; Antidepressive Agents, Second-Generation; Body Mass Index; Body Size; Body Weight; Child; Day Care, Medical; Diagnostic and Statistical Manual of Mental Disorders; Female; Hip; Humans; Insulin Resistance; Leptin; Male; Pilot Projects; Psychotic Disorders; Risperidone; Waist Circumference; Weight Gain | 2010 |
18 other study(ies) available for risperidone and leptin
Article | Year |
---|---|
Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Eating; Leptin; Male; Rats; Rats, Sprague-Dawley; Risperidone; Weight Gain | 2002 |
Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clozapine; Dibenzothiazepines; Female; Follow-Up Studies; Glucose Tolerance Test; Humans; Leptin; Male; Obesity; Olanzapine; Pirenzepine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Risperidone; Schizophrenia; Treatment Outcome; Triglycerides; Weight Gain | 2003 |
Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection.
Topics: Adipocytes; Adipose Tissue; Animals; Antipsychotic Agents; Body Composition; Body Weight; Cell Count; Corticosterone; Dietary Fats; Eating; Energy Metabolism; Female; Leptin; Prolactin; Proteins; Rats; Rats, Wistar; Risperidone; Sulpiride | 2004 |
Serum prolactin, leptin, lipids and lipoproteins levels during antipsychotics treatment in Parkinson's disease and related psychosis.
Topics: Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Dibenzothiazepines; Humans; Leptin; Lipids; Lipoproteins; Olanzapine; Parkinson Disease; Psychotic Disorders; Quetiapine Fumarate; Risperidone | 2006 |
Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.
Topics: Adiponectin; Adult; Antipsychotic Agents; Body Composition; Body Mass Index; Cholesterol, HDL; Female; Ghrelin; Glucose; Humans; Hypertension; Leptin; Lipid Metabolism; Lipids; Male; Middle Aged; Peptide Hormones; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Weight Gain | 2007 |
The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
Topics: Adiposity; Animals; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Composition; Body Weight; Cholesterol; Drinking; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Female; Food Preferences; Glycerol; Insulin; Leptin; Motor Activity; Olanzapine; Piperazines; Prolactin; Rats; Risperidone; Thiazoles; Triglycerides | 2007 |
Contribution of leptin to the formation of neuroleptic obesity in patients with schizophrenia during antipsychotic therapy.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Leptin; Male; Obesity; Olanzapine; Risperidone; Schizophrenia, Paranoid; Sex Factors; Young Adult | 2008 |
Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents.
Topics: Adolescent; Antipsychotic Agents; Base Sequence; Child; DNA Primers; Female; Humans; Leptin; Male; Polymerase Chain Reaction; Risperidone; Weight Gain | 2009 |
Association of serum levels of leptin, ghrelin, and adiponectin in schizophrenic patients and healthy controls.
Topics: Adiponectin; Adult; Antipsychotic Agents; Case-Control Studies; Clozapine; Female; Ghrelin; Humans; Leptin; Male; Metabolic Syndrome; Peptide Hormones; Risperidone; Schizophrenia; Taiwan | 2011 |
Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia.
Topics: Adiponectin; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Cross-Sectional Studies; Diagnostic and Statistical Manual of Mental Disorders; Dibenzothiazepines; Down-Regulation; Female; Humans; Insulin Resistance; Leptin; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Schizophrenia; Up-Regulation; Young Adult | 2012 |
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.
Topics: Adolescent; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Amidohydrolases; Antipsychotic Agents; Body Weight; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Genetic Predisposition to Disease; Humans; Leptin; Male; Proteins; Receptor, Cannabinoid, CB1; Receptor, Melanocortin, Type 4; Risperidone; Weight Gain | 2013 |
Weight gain in risperidone therapy: investigation of peripheral hypothalamic neurohormone levels in psychotic patients.
Topics: alpha-MSH; Antipsychotic Agents; Appetite Regulation; Body Mass Index; Case-Control Studies; Humans; Hypothalamus; Leptin; Male; Nerve Tissue Proteins; Neuropeptide Y; Risperidone; Treatment Outcome; Weight Gain; Young Adult | 2013 |
SOCS3 and SOCS6 are required for the risperidone-mediated inhibition of insulin and leptin signaling in neuroblastoma cells.
Topics: Cell Line, Tumor; Humans; Insulin; Leptin; Neuroblastoma; Phosphorylation; Risperidone; Signal Transduction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins | 2014 |
Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats.
Topics: Agouti-Related Protein; alpha-MSH; Animals; Antipsychotic Agents; Appetite; Eating; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hypothalamus; Leptin; Male; Nerve Tissue Proteins; Neuropeptide Y; Neuropeptides; Pro-Opiomelanocortin; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Risperidone; Statistics, Nonparametric | 2015 |
The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Body Weight; Child; Child, Preschool; Female; Follow-Up Studies; Ghrelin; Homocysteine; Humans; Insulin; Leptin; Male; Obesity; Olanzapine; Prospective Studies; Risperidone; Time Factors; Treatment Outcome; Weight Gain | 2017 |
Impact of risperidone on leptin and insulin in children and adolescents with autistic spectrum disorders.
Topics: Adiponectin; Adolescent; Antipsychotic Agents; Autistic Disorder; Blood Glucose; C-Reactive Protein; Child; Child, Preschool; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Hydrocortisone; Insulin; Insulin Resistance; Leptin; Male; Monitoring, Physiologic; Prolactin; Risperidone | 2017 |
Depot risperidone-induced adverse metabolic alterations in female rats.
Topics: Adipokines; Animals; Antipsychotic Agents; Female; Leptin; Lipids; Rats; Rats, Sprague-Dawley; Risperidone; Weight Gain | 2017 |
Modeling of antipsychotic-induced metabolic alterations in mice: An experimental approach precluding psychosis as a predisposing factor.
Topics: Animals; Antipsychotic Agents; Body Weight; Female; Ghrelin; Hyperglycemia; Leptin; Mice; Mice, Inbred BALB C; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Weight Gain | 2019 |